1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inflammatory bowel disease (IBD) patients are at increased risk for venous thromboembolism (VTE) compared to the general population. Practice guidelines recommend pharmacologic prophylaxis for IBD inpatients.

          Related collections

          Author and article information

          Journal
          J Crohns Colitis
          Journal of Crohn's & colitis
          Elsevier BV
          1876-4479
          1873-9946
          Dec 2013
          : 7
          : 12
          Affiliations
          [1 ] Penn State Hershey Inflammatory Bowel Disease Center, Penn State College of Medicine, Hershey, PA, United States; Division of Gastroenterology and Hepatology, Penn State Hershey Medical Center, Hershey, PA, United States. Electronic address: atinsley@hmc.psu.edu.
          Article
          S1873-9946(13)00177-3
          10.1016/j.crohns.2013.05.002
          23706933
          4ad1b31d-83db-4a71-a320-c81b1305c847
          History

          Deep venous thrombosis;,Venous thromboembolism;,Pulmonary embolism;,Inflammatory bowel disease;,Prophylaxis,Ulcerative colitis;

          Comments

          Comment on this article